124 related articles for article (PubMed ID: 7303836)
1. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
[No Abstract] [Full Text] [Related]
2. [Drug therapy of venopathies].
Esser W
Fortschr Med; 1975 Oct; 93(30):1506-7. PubMed ID: 1225812
[No Abstract] [Full Text] [Related]
3. Anticatatonic effect of venoruton.
Aley KO; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
Artaria LG
Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
[No Abstract] [Full Text] [Related]
5. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
[No Abstract] [Full Text] [Related]
6. [Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
Agolini G; Cavallini GM
Clin Ter; 1987 Jan; 120(2):101-10. PubMed ID: 2972438
[No Abstract] [Full Text] [Related]
7. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
Matagne D; Hamoir G
Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
[No Abstract] [Full Text] [Related]
8. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
Dobbins DE; Soika CY; Dabney JM
Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
[TBL] [Abstract][Full Text] [Related]
9. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
Gábor M
Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
[No Abstract] [Full Text] [Related]
10. [Venalot used in therapy of phlebopathies].
Lacativa AS
Med Welt; 1980 May; 31(19):727-9. PubMed ID: 7421506
[No Abstract] [Full Text] [Related]
11. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of sudden deafness of vascular etiology with venoruton].
Madej S
Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
Gallasch G; Dörfer C; Schmitt T; Stage A
Klin Monbl Augenheilkd; 1985 Jul; 187(1):30-5. PubMed ID: 3906246
[TBL] [Abstract][Full Text] [Related]
14. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
van Haeringen NJ
Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
[No Abstract] [Full Text] [Related]
15. Venoruton in the therapy of central retinal vein occlusion.
Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
[No Abstract] [Full Text] [Related]
16. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
[TBL] [Abstract][Full Text] [Related]
17. Effect of Venoruton on the factor XIII activity in rat plasma.
Grochal M; Sempińska-Edelberg E; Plewiński J
Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
[TBL] [Abstract][Full Text] [Related]
18. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
Bergqvist D; Svensjö E; Arfors KE
Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
[TBL] [Abstract][Full Text] [Related]
19. Venoruton as a radioprotector: a haematological assessment.
Kanwar KC; Shukla VK; Verma A
Radiobiol Radiother (Berl); 1990; 31(6):517-22. PubMed ID: 2101456
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
